Bronchodilator Properties and Safety of a Repeated Dose of V0162 in Asthma.

Trial Profile

Bronchodilator Properties and Safety of a Repeated Dose of V0162 in Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2014

At a glance

  • Drugs V 0162 (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 19 Jul 2014 According to the European Clinical Trials Database record, status changed from recruiting to completed.
    • 19 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Oct 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2013-002517-35).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top